title: Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.
abstract: In order to develop preclinical models of malignant astrocytomas and oligodendrogliomas, a series of 54 resected gliomas (37 from oligodendroglial lineage and 17 from astrocytic lineage) were xenografted subcutaneously into nude mice. Molecular alterations commonly observed in gliomas subtypes, including LOH 1p and 1q, LOH 19q, LOH 10p and 10q, LOH 9p, TP53 and PTEN mutations, EGFR amplification, CDKN2A homozygous deletion and telomerase reactivation were systematically screened in the original and xenografted tumours. In all, 23 gliomas grew in nude mice. The most anaplastic tumours were selected as shown by pathological and molecular studies of the original tumour as well as shorter survival in patients whose tumours were successfully grafted. Comparison between the two growth profiles showed that 10q LOH and EGFR amplification gave a tumorigenic advantage. With a few exceptions, the genetic pattern was remarkably stable before and after growth in nude mice. These results suggest that subcutaneous xenografts are useful and reproducible models to analyse the molecular profile of malignant astrocytoma and oligodendroglioma. This represents the first step to improve our understanding of the correlations between molecular alterations and response to standard or experimental therapies.
authors.affiliation: INSERM U495, Laboratoire de Biologie des Interactions Neurones-Glie, Groupe hospitalier Pitié-Salpêtrière AP-HP, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Leuraud
authors.forename: L
authors.initials: L
authors.lastname: Taillandier
authors.forename: L
authors.initials: L
authors.lastname: Aguirre-Cruz
authors.forename: J
authors.initials: J
authors.lastname: Medioni
authors.forename: E
authors.initials: E
authors.lastname: Crinière
authors.forename: Y
authors.initials: Y
authors.lastname: Marie
authors.forename: A M
authors.initials: AM
authors.lastname: Dutrillaux
authors.forename: M
authors.initials: M
authors.lastname: Kujas
authors.forename: A
authors.initials: A
authors.lastname: Duprez
authors.forename: J-Y
authors.initials: JY
authors.lastname: Delattre
authors.forename: M-F
authors.initials: MF
authors.lastname: Poupon
authors.forename: M
authors.initials: M
authors.lastname: Sanson
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D002455:Cell Division / Q000235:genetics*; D016543:Central Nervous System Neoplasms / Q000235:genetics* / Q000473:pathology*; D005260:Female; D016147:Genes, Tumor Suppressor / Q000502:physiology; D018773:Genes, erbB-1 / Q000235:genetics; D016158:Genes, p53 / Q000235:genetics; D005910:Glioma / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D019656:Loss of Heterozygosity / Q000235:genetics; D008297:Male; D051379:Mice; D008819:Mice, Nude; D008875:Middle Aged; D023421:Models, Animal; D009154:Mutation / Q000235:genetics*; D009368:Neoplasm Transplantation; D051059:PTEN Phosphohydrolase; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics; D011519:Proto-Oncogenes / Q000235:genetics; D019098:Telomerase / Q000235:genetics; D025521:Tumor Suppressor Proteins / Q000235:genetics
chemical_list: D025521:Tumor Suppressor Proteins; D019098:Telomerase; D010744:Phosphoric Monoester Hydrolases; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human